Frits Van Rhee, MD, Hematology, Little Rock, AR, UAMS Medical Center

FritsVan RheeMD

Hematology Little Rock, AR

Professor, Internal Medicine, University of Arkansas COM

Dr. Van Rhee is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Van Rhee's full profile

Already have an account?

  • Office

    4018 W. Capitol Ave.
    Winthrop P. Rockefeller Cancer Institute, Eighth Floor
    Little Rock, AR 72205
    Phone(501) 686-7105
  • Is this information wrong?

Education & Training

  • Erasmus University Rotterdam Faculty of Medicine
    Erasmus University Rotterdam Faculty of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2011 - 2015
  • AR State Medical License
    AR State Medical License 2000 - 2021

Publications & Presentations

PubMed

Abstracts/Posters

  • Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Mye...
    Frits van Rhee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple Myeloma
    Frits van Rhee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma
    Frits van Rhee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Long-Term Outcome of Total Therapy Regimens: Impact of Molecular Subgroups 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The Mutational Landscape of Primary Plasma Cell Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Grant Support

  • Potentiating Natural Killer Cell Anti-Myeloma EffectsNational Cancer Institute2008–2009

Hospital Affiliations